52 related articles for article (PubMed ID: 34032998)
21. Prevalence and Risk of Polypharmacy Among Elderly Cancer Patients Receiving Chemotherapy in Ambulatory Oncology Setting.
Goh I; Lai O; Chew L
Curr Oncol Rep; 2018 Mar; 20(5):38. PubMed ID: 29582192
[TBL] [Abstract][Full Text] [Related]
22. Polypharmacy and medication use by cancer history in a nationally representative group of adults in the USA, 2003-2014.
Hsu CD; Nichols HB; Lund JL
J Cancer Surviv; 2022 Jun; 16(3):659-666. PubMed ID: 34032998
[TBL] [Abstract][Full Text] [Related]
23. Polypharmacy and prescription medication use in a population-based sample of adolescent and young adult cancer survivors.
Betts AC; Murphy CC; Shay LA; Balasubramanian BA; Markham C; Allicock M
J Cancer Surviv; 2023 Aug; 17(4):1149-1160. PubMed ID: 34997910
[TBL] [Abstract][Full Text] [Related]
24. Polypharmacy and medication fill nonadherence in a population-based sample of adolescent and young adult cancer survivors, 2008-2017.
Betts AC; Murphy CC; Shay LA; Balasubramanian BA; Markham C; Roth ME; Allicock M
J Cancer Surviv; 2023 Dec; 17(6):1688-1697. PubMed ID: 36346577
[TBL] [Abstract][Full Text] [Related]
25. Secular Trends in Central Nervous System-Active Polypharmacy Among Serial Cross-Sections of US Adults, 2009-2020.
Terman SW; Niznik JD; Growdon ME; Gerlach LB; Burke JF
Drugs Aging; 2023 Oct; 40(10):941-951. PubMed ID: 37695395
[TBL] [Abstract][Full Text] [Related]
26. Polypharmacy in patients with epilepsy: A nationally representative cross-sectional study.
Terman SW; Aubert CE; Hill CE; Maust DT; Betjemann JP; Boyd CM; Burke JF
Epilepsy Behav; 2020 Oct; 111():107261. PubMed ID: 32629416
[TBL] [Abstract][Full Text] [Related]
27. Endocrine Late Effects in Survivors of Cancer in Adolescence and Young Adulthood: A Danish Population-Based Cohort Study.
Jensen MV; Rugbjerg K; de Fine Licht S; Johansen C; Schmiegelow K; Andersen KK; Winther JF
JAMA Netw Open; 2018 Jun; 1(2):e180349. PubMed ID: 30646084
[TBL] [Abstract][Full Text] [Related]
28. An update on the clinical consequences of polypharmacy in older adults: a narrative review.
Wastesson JW; Morin L; Tan ECK; Johnell K
Expert Opin Drug Saf; 2018 Dec; 17(12):1185-1196. PubMed ID: 30540223
[TBL] [Abstract][Full Text] [Related]
29. Obesity and cancer risk: Emerging biological mechanisms and perspectives.
Avgerinos KI; Spyrou N; Mantzoros CS; Dalamaga M
Metabolism; 2019 Mar; 92():121-135. PubMed ID: 30445141
[TBL] [Abstract][Full Text] [Related]
30. Fertility and pregnancy in cancer survivors.
Tang M; Webber K
Obstet Med; 2018 Sep; 11(3):110-115. PubMed ID: 30214475
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular disease in survivors of childhood cancer.
Bansal N; Amdani SM; Hutchins KK; Lipshultz SE
Curr Opin Pediatr; 2018 Oct; 30(5):628-638. PubMed ID: 30124579
[TBL] [Abstract][Full Text] [Related]
32. Polypharmacy, limited activity, fatigue and insomnia are the most frequent symptoms and impairments in older hematological cancer survivors (70+): Findings from a register-based study on physical and mental health.
Götze H; Köhler N; Taubenheim S; Lordick F; Mehnert A
J Geriatr Oncol; 2019 Jan; 10(1):55-59. PubMed ID: 29880406
[TBL] [Abstract][Full Text] [Related]
33. Polypharmacy and patterns of prescription medication use among cancer survivors.
Murphy CC; Fullington HM; Alvarez CA; Betts AC; Lee SJC; Haggstrom DA; Halm EA
Cancer; 2018 Jul; 124(13):2850-2857. PubMed ID: 29645083
[TBL] [Abstract][Full Text] [Related]
34. Mental health of long-term survivors of childhood and young adult cancer: A systematic review.
Friend AJ; Feltbower RG; Hughes EJ; Dye KP; Glaser AW
Int J Cancer; 2018 Sep; 143(6):1279-1286. PubMed ID: 29468674
[TBL] [Abstract][Full Text] [Related]
35. Early Post-Therapy Prescription Drug Usage among Childhood and Adolescent Cancer Survivors.
Smitherman AB; Mohabir D; Wilkins TM; Blatt J; Nichols HB; Dusetzina SB
J Pediatr; 2018 Apr; 195():161-168.e7. PubMed ID: 29395178
[TBL] [Abstract][Full Text] [Related]
36. What is polypharmacy? A systematic review of definitions.
Masnoon N; Shakib S; Kalisch-Ellett L; Caughey GE
BMC Geriatr; 2017 Oct; 17(1):230. PubMed ID: 29017448
[TBL] [Abstract][Full Text] [Related]
37. Long-term cardiovascular health in adult cancer survivors.
Naaktgeboren WR; Linschoten M; de Graeff A; V Rhenen A; Cramer MJ; Asselbergs FW; Maas AHEM; Teske AJ
Maturitas; 2017 Nov; 105():37-45. PubMed ID: 28583397
[TBL] [Abstract][Full Text] [Related]
38. Cost-related medication nonadherence among adolescent and young adult cancer survivors.
Kaul S; Avila JC; Mehta HB; Rodriguez AM; Kuo YF; Kirchhoff AC
Cancer; 2017 Jul; 123(14):2726-2734. PubMed ID: 28542734
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
